Investor RelationsPresseCOVID-19
  1. Home
  2. Fachbereiche
  3. Theranostics

Theranostics for personalized 
cancer careEmpowering precision oncology

Theranostics at a glance

Graphic of a globe, cancer incidence rates are rising

Cancer incidence rates are rising

Cancer incidence rates continue to rise worldwide with an expectation of 28 million new cases by 2040.1 Taking this outlook into consideration, we are reminded of the need to prioritize precision oncology. 

Theranostics enables precision oncology

Theranostics enables precision oncology

Theranostics (ie, "therapy" + "diagnostics") is an innovative approach to personalized cancer care that involves the use of molecular imaging (eg, PET/CT and SPECT/CT) and radiopharmaceuticals to tailor treatments to an individual patient. It involves the combination of one diagnostic radioactive drug to "see" the disease and a second therapeutic radioactive drug to deliver therapy to "treat" the disease.

The future of theranostics

The future of theranostics

From new radiopharmaceutical therapy development to expanding clinical indications, the adoption of theranostics into clinical practice continues to grow. This growth is triggering the up-scaling of existing and new theranostics centers to meet the demand for this type of personalized, predictive, and precise cancer treatment.

Types of cancer treated with theranostics

The current impact of theranostics is greatest in oncology, where it already plays a key role in the management of prostate cancer, neuroendocrine tumors, thyroid cancer, and liver cancer.

Thyroid cancer

Neuroendocrine tumors

Liver cancer

Prostate cancer

    ​Theranostics care pathway

    Understanding the patient pathway

    ​Theranostics care pathway - Diagnosis and patient selection

    Diagnosis and patient selection

    A radioactive drug and imaging exams help physicians identify cancer cells

    ​Theranostics care pathway - Personalized treatment

    Personalized treatment

    After cancer cells are identified, the right treatment can be selected and delivered

    ​Theranostics care pathway - Therapy response monitoring

    Therapy response monitoring

    Molecular imaging tools help monitor the patient's therapy response

    Patient journeys

    Every patient's theranostics journey is different. Explore these patient stories to learn more. 

    Glenda's journey
    John's journey

    Theranostics for neuroendocrine tumors: Glenda's journey

    1/3
    Meet Glenda01
    Meet the physicians01
    Meet the care team01

    Meet Glenda

    After receiving the diagnosis of neuroendocrine tumors, Glenda's oncologist was unable to provide effective treatment options. Considering her disease burden and noting the progression of the tumors that were difficult to surgically remove, Glenda was referred to Nebraska Cancer Specialists (NCS) for theranostics treatment.

    1/3

    Theranostics for prostate cancer: John's journey

    Meet John

    Enabled by molecular imaging technology, theranostics using a PSMA-targeted radioligand therapeutic agent has the potential to enhance and prolong life for prostate cancer patients such as John. "I was able to feel more of myself. It was remarkable," he says.

    Establishing a theranostics program

    Graphic for Theranostics implementation checklist widget - step 1 Regulatory

    Getting started

    Implementing a theranostics program into an existing practice requires a comprehensive set of considerations including technology investments, staff training, regulatory compliance, strategic partnerships, and financial planning. 

    Explore our practical guide to learn how to build a successful theranostics program.

    Theranostics program implementation checklist

    Refer to this implementation checklist of considerations as you start designing your theranostics program.

    Trusted expertise to help with implementation

    Explore these virtual tours to see how we're collaborating with healthcare institutions to help them integrate theranostics into practice.

    Department for theranostics

    Creating your unique radiopharmaceutical therapy center of excellence

    Theranostics in clinical practice

    Discover how our customers are integrating theranostics into everyday clinical practice. 

    Nebraska Cancer Specialists in the midwestern region of the United States serves as a model of excellence in theranostics.

    Theranostics center of excellence: transforming oncology care

    Nebraska Cancer Specialists in the midwestern region of the United States serves as a model of excellence in theranostics. While caring for the local community and attracting patients from across the country, the center also operates an extensive clinical trials program.

    As a true pioneer in the frontier in cancer treatment, The Comprehensive Cancer Center in Helsinki offers precision therapy personalized to the needs of each individual patient.

    Growing theranostics program is now everyday clinical practice in Finland

    As a true pioneer in the frontier in cancer treatment, The Comprehensive Cancer Center in Helsinki offers precision therapy personalized to the needs of each individual patient. 

    NMNS Theranostics

    Theranostics offers personalized care for prostate cancer

    Professor Joseph R. Osborne, MD, PhD, chief of Molecular Imaging and Therapeutics, and professor of radiology at a leading academic institution’s hospital in New York City, New York, USA, discusses theranostics and its rapidly expanding role in prostate cancer care.

    Your trusted partner in theranostics

    Precision oncology tools at every step of the theranostics care pathway

    There is no one-size-fits-all approach to theranostics, so no matter where your institution is on its theranostics journey, we want to empower you with the tools you need to plan, implement, and expand your program to meet the demands of tomorrow.

    Establish an innovative theranostics program for tomorrow with confidence in our comprehensive value chain and trusted expertise. We are committed to personalizing theranostics solutions for you, so you can focus on personalizing care for patients. 

    Molecular imaging

    Therapy solutions

    Software solutions

    Laboratory diagnostics

    Targeted development

      Ready to establish your theranostics program?

       Let's help patients get the right treatment at the right time.

      1
      Cancer Research UK. Worldwide cancer incidence statistics. Available at https://www.cancerresearchuk.org/health-professional/cancer-statistics/worldwide-cancer/incidence. 
      The products and features (mentioned herein) are not commercially available in all countries. Future availability cannot be guaranteed.
      The statements by Siemens Healthineers customers described herein are based on results that were achieved in the customer’s unique setting. Since there is no “typical” hospital and many variables exist (e.g., hospital size, case mix, level of IT adoption), there can be no guarantee that other customers will achieve the same results.
      ARIA and ARIA CORE are trademarks of Varian Medical Systems, Inc., pending or registered U.S. Pat. & Tm. Off.